CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today financial results for the quarter ended March 31, 2007 and provided financial and operational guidance for fiscal year 2007. The company indicated that its independent registered public accounting firm, Deloitte & Touche LLP, is completing its final concurring partner review.
